Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. Venous access devices that can be implanted under the skin were introduced in 1982. They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods. The CVAD may contain one or two tubes. When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).
In terms of percentage share contribution by product, the peripheral catheters segment is expected to account for 48.24% by 2025, emerging as the leading segment by value.
The central vascular access devices market is largely consolidated, with the top five players accounting for a share of over 69% in 2017. C.R. Bard, Teleflex, Inc., Terumo Corporation, Smiths Medical, Inc and Edwards Lifesciences Corporation are leading the market, other prominent players include Becton Dickinson, B.Braun, Vygon Ltd, AngioDynamics.
According to this study, over the next five years the Central Vascular Access Device market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2410 million by 2024, from US$ 1850 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Central Vascular Access Device business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Central Vascular Access Device market by product type, application, key manufacturers and key regions and countries.
This study considers the Central Vascular Access Device value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
PICC
Centrally Inserted Catheters
Implanted Ports
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Non-Hospital
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Becton Dickinson
C. R. Bard, Inc.
Smiths Medical, Inc
Teleflex Incorporated
B.Braun
NIPRO Medical Corporation
Edwards Lifesciences Corporation
Terumo Corporation
Vygon Ltd.
Ameco Medical
AngioDynamics
Romsons
PRODIMED
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Central Vascular Access Device consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Central Vascular Access Device market by identifying its various subsegments.
Focuses on the key global Central Vascular Access Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Central Vascular Access Device with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Central Vascular Access Device submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.